These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 18297438)

  • 1. Inhibitory effect of branched-chain amino acid granules on progression of compensated liver cirrhosis due to hepatitis C virus.
    Kobayashi M; Ikeda K; Arase Y; Suzuki Y; Suzuki F; Akuta N; Hosaka T; Murashima N; Saitoh S; Someya T; Tsubota A; Kumada H
    J Gastroenterol; 2008; 43(1):63-70. PubMed ID: 18297438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effect of BCAA granules on between decompensated and compensated cirrhosis.
    Habu D; Nishiguchi S; Nakatani S; Lee C; Enomoto M; Tamori A; Takeda T; Ohfuji S; Fukushima W; Tanaka T; Kawamura E; Shiomi S
    Hepatogastroenterology; 2009; 56(96):1719-23. PubMed ID: 20214224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral branched-chain amino acid granules reduce the incidence of hepatocellular carcinoma and improve event-free survival in patients with liver cirrhosis.
    Hayaishi S; Chung H; Kudo M; Ishikawa E; Takita M; Ueda T; Kitai S; Inoue T; Yada N; Hagiwara S; Minami Y; Ueshima K
    Dig Dis; 2011; 29(3):326-32. PubMed ID: 21829025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of nocturnal administration of branched-chain amino acid granules to improve quality of life in patients with cirrhosis.
    Hidaka H; Nakazawa T; Kutsukake S; Yamazaki Y; Aoki I; Nakano S; Asaba N; Minamino T; Takada J; Tanaka Y; Okuwaki Y; Watanabe M; Shibuya A; Koizumi W
    J Gastroenterol; 2013 Feb; 48(2):269-76. PubMed ID: 22825550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of branched-chain amino acids in patients with liver cirrhosis and advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy.
    Kanekawa T; Nagai H; Kanayama M; Sumino Y
    Cancer Chemother Pharmacol; 2014 Nov; 74(5):899-909. PubMed ID: 25138286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis.
    Muto Y; Sato S; Watanabe A; Moriwaki H; Suzuki K; Kato A; Kato M; Nakamura T; Higuchi K; Nishiguchi S; Kumada H;
    Clin Gastroenterol Hepatol; 2005 Jul; 3(7):705-13. PubMed ID: 16206505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of long-term supplementation with branched-chain amino acid granules in patients with hepatitis C virus-related hepatocellular carcinoma after radiofrequency thermal ablation.
    Nishikawa H; Osaki Y; Iguchi E; Koshikawa Y; Ako S; Inuzuka T; Takeda H; Nakajima J; Matsuda F; Sakamoto A; Henmi S; Hatamaru K; Ishikawa T; Saito S; Nasu A; Kita R; Kimura T
    J Clin Gastroenterol; 2013 Apr; 47(4):359-66. PubMed ID: 23090049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Branched-Chain Amino Acid-Enriched Nutrient on liver Cirrhosis with Hepatocellular Carcinoma Undergoing Transcatheter Arterial Chemoembolization in Barcelona Clinic Liver Cancer Stage B: A Prospective Study.
    Shiozawa S; Usui T; Kuhara K; Tsuchiya A; Miyauchi T; Kono T; Asaka S; Yamaguchi K; Yokomizo H; Shimakawa T; Yoshimatsu K; Katsube T; Naritaka Y
    J Nippon Med Sch; 2016; 83(6):248-256. PubMed ID: 28133005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Branched-Chain Amino Acid (BCAA) Supplementation on the Progression of Advanced Liver Disease: A Korean Nationwide, Multicenter, Prospective, Observational, Cohort Study.
    Park JG; Tak WY; Park SY; Kweon YO; Chung WJ; Jang BK; Bae SH; Lee HJ; Jang JY; Suk KT; Oh MJ; Heo J; Woo HY; Jang SY; Lee YR; Lee JS; Kim DY; Kim SH; Suh JI; Kim IH; Kang MK; Lee WK
    Nutrients; 2020 May; 12(5):. PubMed ID: 32429077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of branched-chain amino acids (BCAAs) on the progression of advanced liver disease: A Korean nationwide, multicenter, retrospective, observational, cohort study.
    Park JG; Tak WY; Park SY; Kweon YO; Jang SY; Lee YR; Bae SH; Jang JY; Kim DY; Lee JS; Suk KT; Kim IH; Lee HJ; Chung WJ; Jang BK; Suh JI; Heo J; Lee WK
    Medicine (Baltimore); 2017 Jun; 96(24):e6580. PubMed ID: 28614215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of p53 protein in liver and sera of patients with liver fibrosis, liver cirrhosis or hepatocellular carcinoma associated with chronic HCV infection.
    Attallah AM; Shiha GE; Ismail H; Mansy SE; El-Sherbiny R; El-Dosoky I
    Clin Biochem; 2009 Apr; 42(6):455-61. PubMed ID: 19063876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of branched-chain amino acids in patients receiving intervention for hepatocellular carcinoma.
    Ishihara T; Iwasa M; Tanaka H; Kaito M; Ikoma J; Shibata T; Takei Y
    World J Gastroenterol; 2014 Mar; 20(10):2673-80. PubMed ID: 24627603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early administration of branched-chain amino acid granules.
    Ishikawa T
    World J Gastroenterol; 2012 Sep; 18(33):4486-90. PubMed ID: 22969221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supplementation of branched-chain amino acids maintains the serum albumin level in the course of hepatocellular carcinoma recurrence.
    Kakazu E; Kondo Y; Kogure T; Ninomiya M; Kimura O; Iwata T; Morosawa T; Iwasaki T; Shimosegawa T
    Tohoku J Exp Med; 2013 Aug; 230(4):191-6. PubMed ID: 23892757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Branched-chain amino acids reduce hepatic iron accumulation and oxidative stress in hepatitis C virus polyprotein-expressing mice.
    Korenaga M; Nishina S; Korenaga K; Tomiyama Y; Yoshioka N; Hara Y; Sasaki Y; Shimonaka Y; Hino K
    Liver Int; 2015 Apr; 35(4):1303-14. PubMed ID: 25156780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Branched-chain amino acids ameliorate fibrosis and suppress tumor growth in a rat model of hepatocellular carcinoma with liver cirrhosis.
    Cha JH; Bae SH; Kim HL; Park NR; Choi ES; Jung ES; Choi JY; Yoon SK
    PLoS One; 2013; 8(11):e77899. PubMed ID: 24223741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A snack enriched with oral branched-chain amino acids prevents a fall in albumin in patients with liver cirrhosis undergoing chemoembolization for hepatocellular carcinoma.
    Takeshita S; Ichikawa T; Nakao K; Miyaaki H; Shibata H; Matsuzaki T; Muraoka T; Honda T; Otani M; Akiyama M; Miuma S; Ozawa E; Fujimito M; Eguchi K
    Nutr Res; 2009 Feb; 29(2):89-93. PubMed ID: 19285598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of early interventional therapy of branched-chain amino acid granules in patients with hepatocellular carcinoma: propensity score matching analysis.
    Nishikawa H; Kita R; Kimura T; Ohara Y; Takeda H; Sakamoto A; Saito S; Nishijima N; Nasu A; Komekado H; Osaki Y
    Int J Oncol; 2014 Sep; 45(3):1082-90. PubMed ID: 24969042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-invasive prediction of liver-related events in patients with HCV-associated compensated advanced chronic liver disease after oral antivirals.
    Pons M; Rodríguez-Tajes S; Esteban JI; Mariño Z; Vargas V; Lens S; Buti M; Augustin S; Forns X; Mínguez B; Genescà J
    J Hepatol; 2020 Mar; 72(3):472-480. PubMed ID: 31629779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Branched-chain amino acids suppress the cumulative recurrence of hepatocellular carcinoma under conditions of insulin-resistance.
    Yoshiji H; Noguchi R; Namisaki T; Moriya K; Kitade M; Aihara Y; Douhara A; Yamao J; Fujimoto M; Toyohara M; Mitoro A; Sawai M; Yoshida M; Morioka C; Uejima M; Uemura M; Fukui H
    Oncol Rep; 2013 Aug; 30(2):545-52. PubMed ID: 23708326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.